Manchester Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $149K | Buy |
284
+61
| +27% | +$32K | 0.02% | 390 |
|
|
2025
Q1 | $141K | Buy |
223
+62
| +39% | +$39.3K | 0.02% | 379 |
|
|
2024
Q4 | $115K | Buy |
161
+18
| +13% | +$12.8K | 0.01% | 417 |
|
|
2024
Q3 | $150K | Hold |
143
| – | – | 0.02% | 377 |
|
|
2024
Q2 | $150K | Buy |
143
+69
| +93% | +$72.5K | 0.02% | 357 |
|
|
2024
Q1 | $71.2K | Buy |
74
+9
| +14% | +$8.66K | 0.01% | 434 |
|
|
2023
Q4 | $57.1K | Buy |
65
+10
| +18% | +$8.78K | 0.01% | 417 |
|
|
2023
Q3 | $45.3K | Hold |
55
| – | – | 0.01% | 430 |
|
|
2023
Q2 | $39.5K | Buy |
55
+13
| +31% | +$9.34K | 0.01% | 433 |
|
|
2023
Q1 | $34.5K | Buy |
42
+37
| +740% | +$30.4K | ﹤0.01% | 456 |
|
|
2022
Q4 | $3.61K | Buy |
+5
| New | +$3.61K | ﹤0.01% | 585 |
|
|
2021
Q1 | – | Sell |
-3
| Closed | -$1K | – | 753 |
|
|
2020
Q4 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 682 |
|
|
2015
Q1 | – | Sell |
-35
| Closed | -$14K | – | 804 |
|
|
2014
Q4 | $14K | Buy |
35
+14
| +67% | +$5.6K | ﹤0.01% | 930 |
|
|
2014
Q3 | $8K | Hold |
21
| – | – | ﹤0.01% | 977 |
|
|
2014
Q2 | $6K | Hold |
21
| – | – | ﹤0.01% | 1005 |
|
|
2014
Q1 | $6K | Sell |
21
-11
| -34% | -$3.14K | ﹤0.01% | 906 |
|
|
2013
Q4 | $9K | Sell |
32
-400
| -93% | -$113K | ﹤0.01% | 803 |
|
|
2013
Q3 | $135K | Sell |
432
-339
| -44% | -$106K | 0.02% | 410 |
|
|
2013
Q2 | $173K | Buy |
+771
| New | +$173K | 0.03% | 338 |
|